Skip to main content

Table 1 General characteristic of the guidelines

From: Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review

Guideline title

Organization

Country

Publication

year

Target disorders

Aim

For which patient population is this guideline intended for?

For which healthcare provider is this guideline intended for?

Clinical setting for which this is applicable

Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings [37]

NICE

UK

2011

Psychosis + SUD

To provide diagnosis and treatment recommendations for both disorders.

For all patients above 14 years old with both disorders.

For professionals who provide care in all clinical settings.

All clinical settings and medical services that commissioned by NHS

Coexisting severe mental illness and substance misuse: community health and social care services overview [38]

NICE

UK

2016

Psychosis + SUD

To offer a number of integrated services to meet people’s requirements and solve other related problems, such as lack of housing and joblessness.

For patients above 14 years old with both disorders.

All professionals and commissioners, Workers who have direct contact with patients, The criminal justice system, Voluntary organizations and other third-party sectors, Targeted patients and their families and carers.

Community settings

Guidelines on the management of cooccurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings [39]

Australian government

Australia

2016

Co-occurring alcohol and other drug and mental health conditions

To provide directives in relation to the management of AOD and co-occurring mental health conditions.

Patients with AOD and co-occurring mental health conditions.

AOD workers, including nurses, medical practitioners, psychiatrists, psychologists, counsellors, social workers, and other AOD workers.

AOD treatment settings

Management of schizophrenia [47]

SIGN

UK

2013

Schizophrenia

To provide recommendations for managing schizophrenia.

Adults with schizophrenia

Healthcare providers

Not mentioned specifically

Psychosis and schizophrenia in adults: prevention and management [48]

NICE

UK

2014

Psychosis and schizophrenia

To provide diagnosis and treatment recommendations psychosis and schizophrenia.

Adults with psychosis and schizophrenia

Health care providers who provide services in primary, community, secondary and tertiary clinical settings.

All clinical settings and medical services that commissioned by NHS

Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation [49]

WFSBP

International

2015

Schizophrenia

To issue guidelines relating to the management of schizophrenia and the assessment of pharmacological agents.

Patients with schizophrenia.

Physicians

Not mentioned specifically

Clinical practice guidelines for the management of schizophrenia and related disorders [50]

RANZCP

Australia and New Zealand

2016

Schizophrenia and related disorders

To provide guidance for the treatment of schizophrenia and to provide care for schizophrenic patients.

For patients with schizophrenia and related disorders.

Clinicians such as psychiatrists and GPs, psychiatry trainees, mental health nurses, clinicians who have contact with this patient group, and policymakers.

Not mentioned specifically

Evidence-based guidelines for the pharmacological treatment of schizophrenia [51]

BAP

UK

2019

Schizophrenia

To provide recommendations for the management of schizophrenia.

Patients with schizophrenia

Clinicians

Not mentioned specifically

Practice guideline for the treatment of patients with schizophrenia [52]

APA

US

2020

Schizophrenia

To help clinicians optimize care for their patients and improve quality of care.

Patients with schizophrenia

Clinicians

Not mentioned specifically

Management of Bipolar Disorder in Adults (BD) [53]

VA/DoD

US

2010

Bipolar disorder

To manage patients with bipolar disorder.

People aged 18 years old and older with bipolar disorder.

Healthcare professionals

Not mentioned specifically

Bipolar disorder [54]

Singapore MOH

Singapore

2011

Bipolar disorder

To manage patients with bipolar disorder.

Older patients with bipolar disorder

GP and clinicians

Not mentioned specifically

The assessment and management of bipolar disorder in adults, children and young people in primary and secondary care [55]

NICE

UK

2014

Bipolar disorders

To manage patients with bipolar disorder.

Children, young adults (aged above 13 years old), and adults.

Professionals who provide care in all clinical settings.

All clinical settings and medical services that commissioned by NHS

Evidence-based guidelines for treating bipolar disorder [56]

BAP

UK

2016

Bipolar disorder

To assess and manage patients with bipolar disorder.

Patients with bipolar disorder.

Practitioners

Not mentioned specifically

Guidelines for the management of patients with bipolar disorder [57]

CANMAT and ISBD

Canada

2018

Bipolar disorder

To manage patients with bipolar disorder.

Patients with bipolar disorder

Psychiatrists and primary care providers

Not mentioned specifically

Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity [40]

BAP

UK

2012

SUD

To provide treatment recommendations in order to help clinicians in prescribing medication for patients with SUD alone and those with psychiatric comorbidities.

Young adults and adults with SUD.

Clinicians such as psychiatrists and GPs, professionals in this field, non-specialists, patients and their families.

Not mentioned specifically

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision [41]

WFSBP

International

2017

Substance use and related disorders

To provide recommendations for the treatment of AUD that help clinicians in clinical decision making and subsequently improvement of care

Adult with AUD

Professionals who provide care for patients with AUD.

Not mentioned specifically

Drug misuse and dependence UK guidelines on clinical management [42]

gov.uk

UK

2017

Substance misuse

To provide guidance on managing drug abuse and dependency in the UK.

Drug misusers

Healthcare professionals, Regulatory bodies, Targeted patients, and their families and carers.

Drug misuse services

German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders [43]

DGPPN and DG-Sucht

Germany

2017

Alcohol use disorder

To provide screening, diagnosis, and treatment recommendations for patients with alcohol misuse disorder.

Patients with alcohol misuse disorder and comorbidity psychiatric disorders.

Clinicians

In- and outpatient settings

Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence [44]

NICE

UK

2011

Alcohol use disorder

To provide recommendations for managing patients with alcohol misuse disorder.

Younger children and young adults 10–17 years old with alcohol use disorder.

Professionals who provide care in all clinical settings.

All clinical settings and medical services that commissioned by NHS

Practice guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder [45]

APA

US

2018

Alcohol use disorder

To provide recommendations that help in improving the quality of care and quality of life for patients with AUD.

Patients with AUD

Clinicians

Not mentioned specifically

National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use [46]

ASAM

US

2015

Opioid use disorder

To provide recommendations for managing patients with opioid use disorder.

Patients with opioid use disorder

Physicians; other healthcare providers, medical educators, trainee; and clinical care managers.

Not mentioned specifically

  1. AOD Alcohol and other drug, APA American Psychiatric Association, ASAM American society of addiction medicine, AUD alcohol use disorder, BAP British Association of psychopharmacology, CANMAT and ISBD Canadian Network for Mood and Anxiety Treatments and International Society for Bipolar Disorders, DGPPN and DG-Sucht German Association for Psychiatry, Psychotherapy, and Psychosomatics and the German Association for Addiction Research and Therapy, gov.UK United Kingdom guidelines on clinical management, NICE National Institute for Health and Care Excellence, NIH National health service, RANZCP Royal Australian and New Zealand College of Psychiatrists, SIGN Scottish Intercollegiate Guidelines Network, Singapore MOH Singapore Ministry of Health, SMI Severe mental illness, SUD Substance use disorder, UK United Kingdom, US United States, VA/DoD Department of Veterans Affairs and The Department of Defense, WFSBP World Federation of Societies of Biological Psychiatry